Paris: Sanofi has received orphan drug designation from the US Food and Drug Administration (FDA) for SAR446523, an ...

Sanofi’s SAR446523, a GPRC5D monoclonal antibody, earns orphan drug designation in the US for multiple myeloma ...

Socially vulnerable patients face challenges managing skin diseases, and creating a treatment plan to best meet their needs ...

EWQ offers attractive value, robust dividend yield, and global diversification via French companies with significant ...

Thermo Fisher’s second quarter saw a positive market response, as the company surpassed Wall Street’s revenue and adjusted ...

Multiple myeloma pathogenesis is marked by incredibly complex processes that range beyond primary or acquired genetic alterations, with factors in the ...

The European pharmaceutical industry said Tuesday that it remained concerned a EU-US trade deal reached at the weekend does not provide certainty for critical sector. The EFPIA trade association for ...

After our editorial, the agency relents to allow a Duchenne treatment.

The vaccine maker’s board intends to recommend a pending offer from investment firms Nordic Capital and Permira, which would ...

Net revenue1 of 1,346 million euros, up 2.9%, sustained by organic growth of +2.3% Acceleration in organic growth during the second quarter of ...